[EN] SECOND GENERATION GRP94-SELECTIVE INHIBITORS<br/>[FR] INHIBITEURS SÉLECTIFS DE GRP94 DE SECONDE GÉNÉRATION
申请人:UNIV KANSAS
公开号:WO2019040792A1
公开(公告)日:2019-02-28
The present technology provides compounds selective for the Grp94 isoform, as well as compositions including such compounds, that are useful for treatment of multiple myeloma, melanoma, lung cancer, hepatocellular carcinoma, breast cancer, prostate cancer, and/or glaucoma. Methods using the compounds are also provided.
目前的技术提供了选择性作用于Grp94亚型的化合物,以及包括这些化合物的组合物,这些化合物对于治疗多发性骨髓瘤、黑色素瘤、肺癌、肝细胞癌、乳腺癌、前列腺癌和/或青光眼等疾病是有用的。同时还提供了使用这些化合物的方法。